Published in Hematology Week, July 10th, 2006
According to a review from the United States, "Primary cutaneous T-cell lymphomas encompass a spectrum of non-Hodgkin lymphomas that are characterized by clonal proliferation of skin-homing malignant T lymphocytes. Mycosis fungoides and the leukemic variant Sezary syndrome, collectively referred to as cutaneous T-cell lymphomas, are the most common entities. No curative therapy exists and patients ultimately develop advanced or relapsed disease that is refractory to standard treatment options. Therefore, there is a great need for the development of novel emerging therapies."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week